ROGERS CORP (ROG) Spending and interest coverage
- R&D / revenue · 12 months: Value 3.37%; Formula and calculation Research and development expense / revenue. Period ending 2026-03-31..
- Stock-based compensation / revenue · 12 months: Value 1.10%; Formula and calculation Share-based compensation / revenue. Period ending 2026-03-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 3.37% | Research and development expense / revenue. Period ending 2026-03-31. $27.70M ÷ $820.80M × 100 ≈ 3.37% |
| Stock-based compensation / revenue · 12 months | 1.10% | Share-based compensation / revenue. Period ending 2026-03-31. $9.00M ÷ $820.80M × 100 ≈ 1.10% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 27.70M USD | Research and Development Expense |
| Revenue | 820.80M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 9.00M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -34.00M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $27.70M | $820.80M | $9.00M | $-34.00M | (m) | 3.37% | 1.10% | (m) | (m) |
| 2025-12-31 | $28.10M | $810.80M | $10.90M | $-45.00M | (m) | 3.47% | 1.34% | (m) | (m) |
| 2025-09-30 | $29.60M | $801.50M | $11.60M | $-64.80M | (m) | 3.69% | 1.45% | (m) | (m) |
| 2025-06-30 | $30.30M | $795.80M | $14.20M | $-65.90M | (m) | 3.81% | 1.78% | (m) | (m) |
| 2025-03-31 | $32.80M | $807.20M | $15.20M | $12.90M | (m) | 4.06% | 1.88% | (m) | (m) |
| 2024-12-31 | $34.60M | $830.10M | $15.10M | $24.90M | (m) | 4.17% | 1.82% | (m) | (m) |
| 2024-09-30 | $36.70M | $842.50M | $15.60M | $68.10M | (m) | 4.36% | 1.85% | (m) | (m) |
| 2024-06-30 | $36.40M | $861.30M | $16.10M | $80.70M | (m) | 4.23% | 1.87% | (m) | (m) |
| 2024-03-31 | $35.00M | $878.00M | $15.70M | $97.30M | (m) | 3.99% | 1.79% | (m) | (m) |
| 2023-12-31 | $35.70M | $908.40M | $14.30M | $85.30M | (m) | 3.93% | 1.57% | (m) | (m) |
| 2023-09-30 | $35.27M | $927.52M | $11.09M | $137.43M | (m) | 3.80% | 1.20% | (m) | (m) |
| 2023-06-30 | $36.58M | $945.60M | $10.81M | $128.79M | (m) | 3.87% | 1.14% | (m) | (m) |
| 2023-03-31 | $36.53M | $966.75M | $10.65M | $124.29M | (m) | 3.78% | 1.10% | (m) | (m) |
| 2022-12-31 | $35.21M | $971.17M | $11.80M | $144.43M | (m) | 3.63% | 1.21% | (m) | (m) |
| 2022-09-30 | $33.16M | $977.92M | $15.42M | $72.21M | (m) | 3.39% | 1.58% | (m) | (m) |
| 2022-06-30 | $31.55M | $968.95M | $16.66M | $87.53M | (m) | 3.26% | 1.72% | (m) | (m) |
| 2022-03-31 | $30.99M | $951.89M | $16.19M | $99.88M | (m) | 3.26% | 1.70% | (m) | (m) |
| 2021-12-31 | $29.90M | $932.89M | $16.99M | $117.18M | (m) | 3.21% | 1.82% | (m) | (m) |
| 2021-09-30 | $29.33M | $913.11M | $16.36M | $126.71M | (m) | 3.21% | 1.79% | (m) | (m) |
| 2021-06-30 | $28.88M | $876.79M | $14.90M | $101.70M | (m) | 3.29% | 1.70% | (m) | (m) |
| 2021-03-31 | $28.69M | $833.04M | $14.41M | $87.05M | (m) | 3.44% | 1.73% | (m) | (m) |
| 2020-12-31 | $29.32M | $802.58M | $13.53M | $67.33M | (m) | 3.65% | 1.69% | (m) | (m) |
| 2020-09-30 | $30.59M | $785.68M | $13.33M | $61.94M | (m) | 3.89% | 1.70% | (m) | (m) |
| 2020-06-30 | $31.33M | $805.58M | $13.18M | $83.03M | (m) | 3.89% | 1.64% | (m) | (m) |
| 2020-03-31 | $31.88M | $857.27M | $12.96M | $95.16M | (m) | 3.72% | 1.51% | (m) | (m) |
| 2019-12-31 | $31.68M | $898.26M | $12.30M | $110.48M | (m) | 3.53% | 1.37% | (m) | (m) |
| 2019-09-30 | $31.84M | $927.43M | $11.98M | $122.70M | (m) | 3.43% | 1.29% | (m) | (m) |
| 2019-06-30 | $31.64M | $932.46M | $11.55M | $122.45M | (m) | 3.39% | 1.24% | (m) | (m) |
| 2019-03-31 | $32.55M | $904.28M | $11.03M | $114.47M | (m) | 3.60% | 1.22% | (m) | (m) |
| 2018-12-31 | $33.08M | $879.09M | $11.22M | $112.71M | (m) | 3.76% | 1.28% | (m) | (m) |
| 2018-09-30 | $32.55M | $865.16M | $11.85M | $106.14M | (m) | 3.76% | 1.37% | (m) | (m) |
| 2018-06-30 | $32.33M | $845.08M | $12.30M | $115.70M | (m) | 3.83% | 1.46% | (m) | (m) |
| 2018-03-31 | $30.72M | $831.83M | $13.47M | $122.79M | (m) | 3.69% | 1.62% | (m) | (m) |
| 2017-12-31 | $29.55M | $821.04M | $11.82M | $130.78M | (m) | 3.60% | 1.44% | (m) | (m) |
| 2017-09-30 | $29.18M | $785.03M | $11.25M | $129.64M | (m) | 3.72% | 1.43% | (m) | (m) |
| 2017-06-30 | $29.06M | $743.51M | $10.86M | $113.20M | (m) | 3.91% | 1.46% | (m) | (m) |
| 2017-03-31 | $28.99M | $699.58M | $10.30M | $99.19M | (m) | 4.14% | 1.47% | (m) | (m) |
| 2016-12-31 | $28.58M | $656.31M | $11.28M | $83.85M | (m) | 4.35% | 1.72% | (m) | (m) |
| 2016-09-30 | $28.11M | $636.24M | $10.45M | $78.31M | (m) | 4.42% | 1.64% | (m) | (m) |
| 2016-06-30 | $28.11M | $631.35M | $10.36M | $78.36M | (m) | 4.45% | 1.64% | (m) | (m) |
| 2016-03-31 | $28.09M | $636.96M | $10.04M | $80.18M | (m) | 4.41% | 1.58% | (m) | (m) |
| 2015-12-31 | $27.64M | $641.44M | $9.64M | $76.25M | (m) | 4.31% | 1.50% | (m) | (m) |
| 2015-09-30 | $26.07M | $636.24M | $9.62M | $78.03M | (m) | 4.10% | 1.51% | (m) | (m) |
| 2015-06-30 | $24.76M | $638.92M | $7.98M | $83.36M | (m) | 3.87% | 1.25% | (m) | (m) |
| 2015-03-31 | $24.12M | $629.32M | $7.37M | $79.07M | (m) | 3.83% | 1.17% | (m) | (m) |
| 2014-12-31 | $22.88M | $610.91M | $7.53M | $80.43M | (m) | 3.74% | 1.23% | (m) | (m) |
| 2014-09-30 | $22.02M | $599.42M | $7.34M | $77.42M | (m) | 3.67% | 1.22% | (m) | (m) |
| 2014-06-30 | $21.41M | $579.18M | $7.72M | $68.03M | (m) | 3.70% | 1.33% | (m) | (m) |
| 2014-03-31 | $21.24M | $558.14M | $6.46M | $59.92M | (m) | 3.81% | 1.16% | (m) | (m) |
| 2013-12-31 | $21.65M | $537.48M | $5.39M | $49.28M | (m) | 4.03% | 1.00% | (m) | (m) |
| 2013-09-30 | $21.59M | $525.43M | $5.08M | $44.76M | (m) | 4.11% | 0.97% | (m) | (m) |
| 2013-06-30 | $21.03M | $511.74M | $4.72M | $36.08M | (m) | 4.11% | 0.92% | (m) | (m) |
| 2013-03-31 | $19.26M | $504.58M | $4.40M | $36.98M | (m) | 3.82% | 0.87% | (m) | (m) |
| 2012-12-31 | $19.31M | $498.76M | $5.15M | $25.66M | (m) | 3.87% | 1.03% | (m) | (m) |
| 2012-09-30 | $20.10M | $504.67M | $6.15M | $23.64M | (m) | 3.98% | 1.22% | (m) | (m) |
| 2012-06-30 | $20.63M | $521.76M | $7.16M | $31.45M | (m) | 3.95% | 1.37% | (m) | (m) |
| 2012-03-31 | $21.76M | $538.60M | $8.68M | $38.89M | (m) | 4.04% | 1.61% | (m) | (m) |
| 2011-12-31 | $21.62M | $553.15M | $8.10M | $52.80M | (m) | 3.91% | 1.46% | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $17.45M | $378.20M | $6.63M | $31.22M | (m) | 4.61% | 1.75% | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $17.39M | $291.60M | $4.68M | $-25.83M | (m) | 5.97% | 1.60% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AVIENT CORP (AVNT) | United States | $3.739B | 19.95 |
| PureCycle Technologies, Inc. (PCT) | United States | $0.975B | -7.32 |
| AdvanSix Inc. (ASIX) | United States | $0.426B | -30.25 |
| HEXCEL CORP /DE/ (HXL) | United States | $6.464B | 49.18 |
| EASTMAN CHEMICAL CO (EMN) | United States | $7.575B | 17.34 |
| ALBEMARLE CORP (ALB) | United States | $12.778B | 71.05 |
| DuPont de Nemours, Inc. (DD) | United States | $17.580B | 1,010.90 |
| DOW INC. (DOW) | United States | $20.577B | -11.55 |